Takashi Kei Kishimoto
2021
In 2021, Takashi Kei Kishimoto earned a total compensation of $1.3M as Chief Scientific Officer at SELECTA BIOSCIENCES, a 62% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $160,000 |
|---|---|
| Option Awards | $526,588 |
| Salary | $399,798 |
| Stock Awards | $214,133 |
| Other | $6,156 |
| Total | $1,306,675 |
Kishimoto received $526.6K in option awards, accounting for 40% of the total pay in 2021.
Kishimoto also received $160K in non-equity incentive plan, $399.8K in salary, $214.1K in stock awards and $6.2K in other compensation.
Rankings
In 2021, Takashi Kei Kishimoto's compensation ranked 7,800th out of 12,412 executives tracked by ExecPay. In other words, Kishimoto earned more than 37.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,800 out of 12,412 | 37th |
Division Manufacturing | 3,441 out of 5,498 | 37th |
Major group Chemicals And Allied Products | 1,532 out of 2,374 | 36th |
Industry group Drugs | 1,361 out of 2,095 | 35th |
Industry Pharmaceutical Preparations | 1,004 out of 1,542 | 35th |
Source: SEC filing on May 3, 2022.
Kishimoto's colleagues
We found six more compensation records of executives who worked with Takashi Kei Kishimoto at SELECTA BIOSCIENCES in 2021.
2021
Carsten Brunn
SELECTA BIOSCIENCES
Chief Executive Officer
2021
Kevin Tan
SELECTA BIOSCIENCES
Chief Financial Officer
2021
Peter Traber
SELECTA BIOSCIENCES
Chief Medical Officer
2021
Lloyd Johnston
SELECTA BIOSCIENCES
Chief Operations Officer
2021
Bradford Dahms
SELECTA BIOSCIENCES
Chief Financial Officer
2021
Ann Donohue
SELECTA BIOSCIENCES